Tudóstér has been updated, the site is accessible at https://tudoster.unideb.hu

Halmi Sándor

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2015-2024

2024

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry (2023)

Q2 Endocrinology, Diabetes and Metabolism (2023)

Q2 Molecular Biology (2023)

Halmi, S., Berta, E., Diószegi, Á., Sira, L., Fülöp, P., Nagy, E. V., Győry, F., Kanyári, Z., Tóth, J., Bhattoa, H. P., Bodor, M.: Single center experience in localization of insulinoma by selective intraarterial calcium stimulation angiography: a case series of 15 years.
Front Endocrinol (Lausanne). 15, 1-7, (article identifier: 1305958), 2024.

doi DEA

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism (2023)

2023

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (article identifier: 1187725), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

Gál, K., Halmi, S., Németh, N., Gálné Remenyik, J., Soltész, P.: Monitoring and recovery of hyperglicaemia-induced endothelial dysfunction with rheopheresis in diabetic lower extremity ulceration with hyperviscosity.
Diabetes Technol. Ther. 25 (Suppl.), A-200, 2023.

doi DEA

2022

Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81, EP400, 2022.

doi DEA

Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E. V., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355, e247-e248, 2022.

doi DEA

Gál, K., Veres, K., Halmi, S., Bozoki-Beke, K., Fekete, K., Homoki, J., Gálné Remenyik, J., Baráth, B., Varga, Á., Németh, N., Soltész, P.: The effect of rheopheresis treatment on the cytokine profile in diabetic foot syndrome with hyperviscosity in the aspect of clinical changes: a preliminary study.
Clin. Hemorheol. Microcirc. 80 (2), 117-125, 2022.

doi DEA WoS Scopus

Journal metrics:

Q3 Cardiology and Cardiovascular Medicine

Q3 Hematology

Q3 Physiology

Q3 Physiology (medical)

2021

Szilágyi, B., Fejes, Z., Rusznyák, Á., Fenyvesi, F., Pócsi, M., Halmi, S., Griger, Z., Kunapuli, S. P., Kappelmayer, J., Nagy, B. J.: Platelet Microparticles Enriched in miR-223 Reduce ICAM-1-Dependent Vascular Inflammation in Septic Conditions.
Front. Physiol. 12, 1-14, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Physiology

Q1 Physiology (medical)

Berta, E., Bodor, M., Halmi, S., Lengyel, I., Diószegi, Á., Katkó, M., Seres, I., Nagy, E. V., Paragh, G., Harangi, M.: Strong correlations between serum fibroblast growth factor 21 level and lipid parameters in patients with autoimmune thyroiditis.
Atherosclerosis. 331, e201, 2021.

doi DEA WoS

2019

10.

Berta, E., Lengyel, I., Halmi, S., Puskás, I., Felszeghy, E. N., Balogh, Z., Nagy, E. V., Bodor, M.: Control of hyperglycemia in a young male patient with gigantism during transition: a case report.
Endocrine Abstracts. 63, P719, 2019.

doi DEA

11.

Berta, E., Lengyel, I., Halmi, S., Zrínyi, M., Erdei, A., Harangi, M., Páll, D., Nagy, E. V., Bodor, M.: Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10, 1-11, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

2015

12.

Berta, E., Ujhelyi, B., Szabados, L., Galuska, L., Erdei, A., Gazdag, A., Halmi, S., Nagy, E. V., Bodor, M.: There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37, GP, 2015.

doi DEA